The role of B lymphocytes in the development of Parkinson’s disease and its associated dementia.

Award Number
106565/Z/14/A
Status / Stage
Completed
Dates
1 May 2015 -
31 August 2018
Duration (calculated)
03 years 03 months
Funder(s)
Wellcome Trust
Funding Amount
£22,027.00
Contracted Centre
University of Cambridge
Principal Investigator
Dr Kirsten Scott
PI ORCID
0000-0003-3121-5963
WHO Catergories
Understanding Underlying Disease
Disease Type
Parkinson's Dementia

CPEC Review Info
Reference ID310
ResearcherReside Team
Published12/06/2023

Data

Award Number106565/Z/14/A
Status / StageCompleted
Start Date20150501
End Date20180831
Duration (calculated) 03 years 03 months
Contracted CentreUniversity of Cambridge
Funding Amount£22,027.00

Abstract

Parkinson’s disease (PD) is common, affecting between 2-3% of people over the age of 65 with over half of patients developing dementia within ten years. This causes a decline in function and often leads to nursing home care. The involvement of the immune system in PO has been well described but it remains unclear whether this is an epiphenomenon. I hypothesise that the immune response to PO associated pathology contributes to disease progression, increasing the risk of dementia. My PhD will look at the role played by 8 lymphocytes as most research has focused on T lymphocytes or the innate immune system. I aim to characterise the 8 lymphocyte response associated with alpha synuclein pathology in both the mouse and human brain and to identify whether there are perturbations in the systemic 8 cell compartment in patients at high risk of dementia versus those who have a low risk. Using two mouse models of PO I will manipulate B cells to see whether 8cell depletion, antibody depletion or manipulation of 8 cell regulatory activity alters disease course thereby confirming causation in an animal model.